COMMON STOCK | 6 Months Ended |
Mar. 31, 2015 |
COMMON STOCK [Abstract] | |
COMMON STOCK | NOTE 8: COMMON STOCK |
|
Common Stock |
|
The Company did not issue any common shares during the six months ended March 31, 2015. |
|
Stock Options |
|
On April 25, 2007, Arkanova adopted a stock option plan named the 2007 Stock Option Plan (the “Plan”), the purpose of which is to attract and retain the best available personnel and to provide incentives to employees, officers, directors and consultants, all in an effort to promote the success of Arkanova. Prior to the grant of options under the 2007 Stock Option Plan, there were 5,000,000 shares of Arkanova’s common stock available for issuance under the plan. |
|
On July 17, 2010, Arkanova amended and restated the 2008 Amended Stock Option Plan to revise the termination provision for vested Non-Qualified Stock Options. The termination date of vested Non-Qualified Stock Options was extended from a period of three months to a period of one year. |
|
On November 1, 2014, Arkanova granted 100,000 stock options valued at $3,871 with immediate vesting to an employee to acquire 100,000 stock options at an exercise price of $0.10 per share expiring in 5 years. The grant date fair value of the options using the Black-Scholes option pricing model was $0.04 per share using the following assumptions: |
|
Expected dividend yield | 0.00% | | | | | | | | | | | |
Expected volatility | 206% | | | | | | | | | | | |
Expected life (in years) | 5 | | | | | | | | | | | |
Risk-free interest rate | 1.62% | | | | | | | | | | | |
|
During the six months ended March 31, 2015 and 2014, no stock options were exercised. Stock-based compensation of $3,871 (2014 - $101,967) was recorded for the six months ended March 31, 2015. During the six months ended March 31, 2015 and 2014, no stock options expired unexercised and 250,000 (2013 – nil) stock options were cancelled. |
|
A summary of Arkanova’s stock option activity is as follows: |
|
| | | | | | | | Weighted | | | | |
| | | | | | | | Average | | | Aggregate | |
| | Number of | | | Weighted Average | | | Remaining | | | Intrinsic | |
| | Options | | | Exercise Price | | | Contractual Term | | | Value | |
| | | | | | | | | | | | |
| | | | | | | | | | | | |
Outstanding, September 30, 2014 | | 4,800,000 | | $ | 0.05* | | | | | | | |
| | | | | | | | | | | | |
Granted | | 100,000 | | | 0.05* | | | | | | | |
Cancelled | | (250,000 | ) | | (0.10 | ) | | | | | | |
| | | | | | | | | | | | |
Outstanding, March 31, 2015 | | 4,650,000 | | $ | 0.05* | | | | | | | |
| | | | | | | | | | | | |
Exercisable, March 31, 2015 | | 4,650,000 | | $ | 0.05* | | | 3.83 | | $ | – | |
|
* On February 25, 2015, Arkanova amended the terms of the outstanding stock options to decrease the exercise prices from $0.10 to $0.05. The weighted average grant date fair value of the modified stock options was $0.02 and Arkanova recognized an additional stock-based compensation expense of $1,519 related to the modification. |
|
The fair value of each option amendment was estimated on the date of the amendment using the Black-Scholes option pricing model with the following weighted average assumptions: |
|
| | Pre - | | | Post - | | | | | | | |
| | Amendment | | | Amendment | | | | | | | |
| | | | | | | | | | | | |
Expected dividend yield | | 0.00% | | | 0.00% | | | | | | | |
Expected volatility | | 220% | | | 220% | | | | | | | |
Expected life (in years) | | 3.92 | | | 3.92 | | | | | | | |
Risk-free interest rate | | 1.20% | | | 1.20% | | | | | | | |
|
At March 31, 2015, there was $0 of unrecognized compensation costs related to non-vested share-based compensation arrangements granted under the Plan. There was $0 intrinsic value associated with the outstanding options at March 31, 2015. |